A new study hits on ground that PD can be found to treat using Gene therapy by targeting alpha-synuclein -the toxic aggregated protein which causes to disrupt Neuronal Circuit .
" Our results showed that gene therapy using alpha-synuclein-targeting ASOs is a promising strategy for the control and prevention of [Parkinson's disease]. We expect that in the future, this method will be used to not only successfully treat [Parkinson's disease], but also dementia caused by alpha-synuclein accumulation." Senior author Dr. Hideki Mochizuki .
More about the story :